Research on Glaxo Malaria Vaccine

By | September 15, 2009

Malaria is still a fatal disease in many under-developed parts of well-developed world. Sometimes it may also lead to brain infection. Even though we have partially effective vaccine, it cannot save the life of the infected person. Recently our researchers proved that Glaxo malaria vaccine can defend babies and children from infection up to 65 percent.

The tests which were conducted in Kenya and Tanzania proved that Glaxo vaccine called RTS, S protect babies and toddlers from infection with malaria and prevents the disease who are infected by malaria.

According to the World Health Organization, it is estimated that malaria killed 750000 people and 250 million people are infected worldwide in the last year. It is difficult to fight as people are frequently tainted by mosquitoes throughout their lives. Tiny vermins get into the blood and reproduce inside the body, causing fever and sometimes deadly brain infections. So it is better to use mosquito killers in the home instead of exposing to the risk.

Suggested Reading:
Surgeon’s find their new strategy working
Influenza – The Viral Infection
All about Plastic Surgery
Difference Between Health plan and Health Insurance
Top Five Foods for Beautiful Skin
Michael Jackson is critically suffering from lung disease